Quick infos Headquarters: La Jolla, California, United States Trade prices Volume: Market Cap: 452.05M Prev closed: 27.5 Open: 27.47 High: 27.75 Low: 26.27 52 week low: 14.27 52 week high: 50.97 Dividends: No Dividends Next ER: March 13, 2023 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 March 6, 2023 -0.95 / -0.788274K / 994KNovember 18, 2022 - / -0.8962- / 902.58KNovember 7, 2022 -0.9 / -0.9412278K / 633.33KAugust 8, 2022 -0.97 / -0.7786711K / 1.07MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 15, 2022 24.73 24.06 24.79
23.50
234.01K 1.10% Aug 12, 2022 24.46 23.86 25.62
23.14
358.76K 3.95% Aug 11, 2022 23.53 23.99 25.10
23.26
445.08K -0.3% Aug 10, 2022 23.60 25.00 25.31
22.65
561.86K -3.83% Aug 9, 2022 24.54 23.92 25.52
23.51
446.49K -0.77% Aug 8, 2022 24.73 22.84 25.19
20.56
503.46K 8.27% Aug 5, 2022 22.84 19.39 23.29
19.39
340.87K 13.86% Aug 4, 2022 20.06 18.40 20.24
18.12
185.50K 9.32% Aug 3, 2022 18.35 17.48 19.44
17.29
271.57K 4.62% Aug 2, 2022 17.54 16.47 17.72
16.47
245.14K 5.03% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Inhibrx Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights finance.yahoo.com Dec 3, 2022 4:05 pm
Inhibrx Announces Opportunity for Accelerated Approval Pathway on Functional AAT Serum Levels for INBRX-101 in AATD and Announces Bronchoalveolar Lavage Fluid Detection Results from the Phase 1 Study finance.yahoo.com Dec 3, 2022 8:00 am
Inhibrx Announces Participation in Upcoming Investor Conference finance.yahoo.com Nov 18, 2022 4:05 pm Inhibrx's drug for rare bone cancer shows promise in ongoing phase 1 study seekingalpha.com Nov 16, 2022 10:37 pm
Inhibrx Posts Updated Efficacy, Safety Data From Expansion Cohorts Of Bone Cancer Candidate finance.yahoo.com Nov 16, 2022 10:42 am
Inhibrx Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag finance.yahoo.com Nov 9, 2022 6:08 am Inhibrx GAAP EPS of -$0.90 beats by $0.04, revenue of $0.28M misses by $0.29M seekingalpha.com Nov 8, 2022 6:03 am
Investors in Inhibrx (NASDAQ:INBX) have unfortunately lost 18% over the last year finance.yahoo.com Oct 13, 2022 6:56 am Inhibrx stock soars 33% on potential accelerated approval path for INBRX-101 after FDA discussions seekingalpha.com Oct 4, 2022 11:42 pm Inhibrx down 8% after announcing webcast for pathway for rare disease candidate seekingalpha.com Oct 4, 2022 5:58 am
Inhibrx To Host Webcast to Announce Regulatory Pathway for INBRX-101, its Optimized Recombinant Human AAT-Fc Protein for the Treatment of Alpha-1 Antitrypsin Deficiency finance.yahoo.com Oct 3, 2022 4:30 pm
Cara Therapeutics (CARA) Reports Q1 Loss, Lags Revenue Estimates finance.yahoo.com Aug 26, 2022 5:25 pm
Inhibrx Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights finance.yahoo.com Aug 26, 2022 5:19 pm Here's Why Inhibrx Stock Is on the Move Today fool.com Aug 26, 2022 12:11 pm
Inhibrx Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights finance.yahoo.com Aug 26, 2022 4:05 pm
INBRX-101 Shows Favorable Safety Profile in Patients with Alpha-1 Antitrypsin Deficiency and Demonstrates Potential to Achieve Normal Functional Alpha-1 Antitrypsin Levels with Monthly Dosing finance.yahoo.com Aug 26, 2022 9:00 am Europe drug regulator grants orphan designation to Inhibrx's drug for type of bone cancer seekingalpha.com Aug 16, 2022 4:38 am
European Medicines Agency Grants Orphan Drug Designation to INBRX-109 for the Treatment of Chondrosarcoma finance.yahoo.com Aug 15, 2022 4:05 pm Inhibrx GAAP EPS of -$0.97 misses by $0.19, revenue of $0.71M misses by $0.36M seekingalpha.com Aug 9, 2022 5:52 am
Inhibrx, Inc. (INBX) Reports Q2 Loss, Lags Revenue Estimates finance.yahoo.com Aug 8, 2022 7:25 pm This company doesn't provide a dividend.
Talk about Inhibrx below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology
